About Flow Pharma

Flow Pharma offers a T-Cell based vaccine delivery platform. The vaccine platform has been tested in an HIV vaccine application (Immunity Project program in partnership with Until There’s A Cure) yielding promising results in animals and in human blood. Flow Pharma is now using a similar approach to develop a vaccine for Ebola, Marburg, and triple negative breast cancer.

Company Highlights
Year Founded

2002

icon-altEmployees

9

Location (HQ)

USA

Since Last Funding

3 years 8 months

Monthly Website Visitors

3.3K

icon-altTotal Investment Amt

$24M

icon-altYoY Headcount Growth

-18.02%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical

Delivery